Navigation Links
Nestlé Recalls Cookie Dough Products
Date:6/19/2009

Move comes after FDA reports 66 cases of E. coli infection in 28 states

FRIDAY, June 19 (HealthDay News) -- U.S. health officials are warning consumers not to eat any Nestlé Toll House refrigerated cookie dough products because of the risk of E. coli contamination.

In response to the Food and Drug Administration warning, Nestlé USA said Friday that it was voluntarily recalling its Toll House refrigerated cookie dough items.

"The E. coli outbreak could be from one or a number of contaminates, such as the milk component, the machinery, even the harvested flour," said one expert in infectious disease, Dr. Philip M. Tierno, director of clinical microbiology and immunology at New York University Langone Medical Center.

"Whether eaten or handled (causing cross-contamination), the dough is a danger, especially to the elderly, anyone with a suppressed immune system or pregnant women and should be discarded," he said.

Since March there have been 66 reports of illness in 28 states, the agency said. Twenty-five people have been hospitalized, seven with a severe complication called hemolytic uremic syndrome, which can result in kidney damage and even death. There have been no deaths, the FDA said.

The FDA is advising consumers to toss out any refrigerated Nestlé Toll House cookie dough products they have in their homes. The agency also says not to cook the dough because E. coli bacteria could get on your hands and cooking surfaces, leading to cross-contamination.

Retailers, restaurateurs, and other food-service operations should not sell or serve any Nestlé Toll House refrigerated cookie dough, the agency added.

The recall includes refrigerated cookie and brownie dough bar, cookie dough tub, cookie dough tubes, seasonal cookie and brownie dough, and Ultimates cookie bar dough. It does not include any other Toll House products, the company said in a news release.

Nestlé spokeswoman Roz O'Hearn said "this has been a very quickly moving situation," adding that the company took action less than 24 hours after hearing of the problem.

O'Hearn said the company will "cooperate fully" with the FDA's investigation, the Associated Press reported.

E. coli. can cause abdominal cramps, vomiting and diarrhea, often with bloody stools. Most healthy adults recover within a week. Young children and the elderly are at highest risk for developing hemolytic uremic syndrome, the FDA said.

More information

For more on E. coli, visit the U.S. Centers for Disease Control and Prevention.



SOURCES: Philip M. Tierno, M.D., director, Clinical Microbiology and Immunology, New York University Langone Medical Center, and clinical professor of microbiology and pathology, New York University School of Medicine, New York City; June 19, 2009, news release, U.S. Food and Drug Administration; Associated Press


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Nestlé Recalls Raw Cookie Dough Products
2. Pausing Hormone Therapy Doesnt Cut Mammogram Recalls
3. De Jong Bros. Recalls Spinach Because of Possible Health Risk
4. FDA Recalls Dietary Supplements Tied to 1 Death, Liver Damage
5. National Archives Recalls Flu Pandemic of 1918
6. Kroger Recalls Lite Mayo Due to Possible Health Risk
7. Kroger Recalls Shelled Pistachios Due to Possible Health Risk
8. Kroger Recalls Nut Topping Due to Possible Health Risk
9. Salmonella Infection Numbers Still Rising; Recalls Rise Also
10. Kroger Recalls Select Ice Cream Products Due to Possible Health Risk
11. Peanut Butter Product Recalls Mount
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical companies are held ... with process innovation in drug formulation and manufacturing. CoreRx offers its clients ... equipment in support of their development and manufacturing goals. , The company ...
(Date:4/25/2017)... ... April 25, 2017 , ... Back Pain Centers ... back pain with a reputable physician in their area, announces the launch of a ... information for patients who are looking for reputable physicians to help them with back ...
(Date:4/25/2017)... ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the highest ... chronic problems, I focus on preventative care with all my patients to alleviate possible future ... always feel free to contact my office and my trained staff will assist you in ...
(Date:4/25/2017)... ... April 25, 2017 , ... Emergency Physician and Distinguished Professor of Emergency ... Series, Outliers in Writing, set to publish in summer 2017. , Dr. Bobrow, ... University of Arizona College of Medicine. He also serves as Medical Director for the ...
(Date:4/25/2017)... ... ... Vetoquinol USA® , a world-class developer of veterinarian-approved ... EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. Flexadin UCII ... The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage and joints. ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: ... that address significant unmet medical needs, today announced ... Company,s consumer product development program, based on its ... for Investigative Dermatology (SID) 76 th Annual ... promote the sciences relevant to skin health and ...
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
(Date:4/20/2017)... Research and Markets has announced the addition of ... By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, Argentina, ... to their offering. ... The Latin American pharmaceutical contract manufacturing services market is anticipated ... drug registration cost in Latin American countries and continuous economic ...
Breaking Medicine Technology: